Industry / Spain

Growth In Healthcare Spending To Slow Down

March 2011 | Industry Trend Analysis

Printable version
Bookmark

BMI View: Many developed countries will overhaul their healthcare systems, driven by the need to contain escalating healthcare costs as populations age.

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Cost Containment Measures Depress The Pharmaceutical Market

Industry / Spain BMI Core View: Governments will increasingly impose price controls on pharmaceuticals. Drugmakers have generally charged what the market will bear in both developed and emerging countries. High prices...

March 2011

Price Cuts Hurt Almirall's 2010 Results

Industry / Spain Reinforcing BMI's view that companies with significant exposure to European markets will be hard hit by government austerity measures across the region, and in particular by pharmaceutical price erosion...

March 2011

More Gloom For Drugmakers

Industry / Spain BMI Core View: The introduction of government price erosion mechanisms will accelerate across Europe, driven by the need for fiscal austerity and presaged by the actions of numerous governments over the...

May 2010

Government To Maintain 4% Tax Rate On Medicines

Industry / Spain With the aim of increasing government revenues (to cover the growth in public sector spending as a recession grips Spain) and decrease its budget deficit (forecast to equal to 8.1% of GDP in 2010), the...

October 2009

European Court Of Justice Requests European Commission To Reconsider Dual Pricing And Parallel Trade

Industry / Spain The European Court of Justice (ECJ) has said that EU antitrust regulators must reconsider their decision that drugmakers that prevent traders from exploiting price differences across Europe are restricting...

October 2009